肥胖与子宫内膜癌血管生成相关基因表达改变
研究评估肥胖与子宫内膜癌血管生成相关基因表达的关联,利用TCGA子宫内膜癌队列、GYN-COE验证队列及LKB1fl/flp53fl/fl小鼠模型。小鼠高脂饮食组Edil3表达升高2.5倍,且饮食与二甲双胍存在交互作用;GYN-COE队列中EDIL3表达与BMI关联在一个探针集中得到验证。结论提示肥胖可能通过调控血管生成通路促进EEC进展,EDIL3为候选基因。
要点
- 小鼠高脂饮食组Edil3表达较低脂饮食组升高2.5倍(未校正P=0.03)。
- GYN-COE队列中EDIL3表达与BMI关联在一个探针集得到验证(校正P=0.0342)。
核心结论
- 肥胖可能通过差异调控血管生成通路促进子宫内膜样内膜癌进展。
- EDIL3可能是值得关注的候选基因。
研究设计与样本
- 研究分析TCGA子宫体子宫内膜癌队列中子宫内膜样内膜癌(n=290)和拷贝数高队列(n=55)的168个人血管生成相关基因与BMI的关联。
- 独立验证队列来自GYN-COE(n=62),并在LKB1fl/flp53fl/fl小鼠模型(n=20)中评估185个同源小鼠基因。
- 小鼠高脂饮食(60%热量来自脂肪)模拟饮食诱导肥胖,低脂饮食为10%热量来自脂肪;肿瘤生长后高脂饮食(n=5)和低脂饮食(n=5)小鼠接受二甲双胍(200 mg/kg/day)或对照治疗。
主要发现
- 小鼠模型对照组中,高脂饮食较低脂饮食小鼠Edil3表达升高2.5倍(未校正P=0.03)。
- Edil3表达存在饮食与二甲双胍治疗的交互作用(未校正P=0.009)。
- GYN-COE队列中,四个EDIL3探针集之一验证了BMI与EDIL3表达升高的关联(P=0.0011,校正P=0.0342)。
临床怎么用
- 对肥胖子宫内膜癌患者,可关注血管生成相关通路及EDIL3表达的潜在临床意义。
- 饮食与二甲双胍可能交互影响Edil3表达,提示代谢干预联合治疗值得进一步研究。
局限性
- EDIL3仅在四个探针集之一中验证,需更多队列验证。
- 小鼠模型样本量小(高脂饮食n=5,低脂饮食n=5)。
- 研究为探索性分析,未提供机制性证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Evaluate association between obesity and angiogenic-related gene expression in endometrial cancer (EC). Evaluate interaction between diet and metformin on angiogenic-related gene expression. METHODS: We evaluated the association between 168 human angiogenic-related genes and body mass index (BMI) in the TCGA Uterine Corpus Endometrial Carcinoma cohort (endometrioid endometrial cancer (EEC) cohort n = 290, and copy number high cohort n = 55), an independent validation cohort from Gynecologic Cancer Center of Excellence (GYN-COE) (n = 62) and corresponding 185 homologous mouse genes in an LKB1fl/flp53fl/fl mouse model of EC (n = 20). Mice received 60% of calories from fat in a high-fat diet (HFD), mimicking diet-induced obesity, versus 10% of calories from fat in a low-fat diet (LFD). After tumor growth, HFD (n = 5) and LFD (n = 5) mice were treated with metformin (200 mg/kg/day) or control. Whole transcriptome analysis of mouse tumors was performed using RNA-Seq. RESULTS: At a false-discovery rate of 10%, twenty-one angiogenic-related genes were differentially expressed with respect to BMI when adjusting for grade in the TCGA EEC cohort. Evaluation of these genes in the mouse model control group revealed association between increased Edil3 expression in HFD versus LFD mice (2.5-fold change (FC); unadjusted p = 0.03). An interaction was observed for expression of Edil3 between diet and metformin treatment (unadjusted p = 0.009). Association between BMI and increased expression of EDIL3 was validated in one of four EDIL3 probesets in the GYN-COE cohort (p = 0.0011, adjusted p = 0.0342). CONCLUSIONS: Obesity may promote tumor progression via differential modulation of angiogenic pathways in EEC. Our exploratory findings demonstrated that EDIL3 may be a candidate gene of interest.
引用
- Cobb LP, Siamakpour-Reihani S, Zhang D, et al. Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecol Oncol. 2021. PMID: 34538531. doi:10.1016/j.ygyno.2021.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。